Market revenue in 2023 | USD 353.6 millions |
Market revenue in 2030 | USD 538.9 millions |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Production |
Fastest growing segment | Companion |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD millions |
Market segmentation | Companion, Production |
Key market players worldwide | BioMerieux SA, Becton Dickinson & Co, Synbiosis, Thermo Fisher Scientific Inc, Bruker Corp, Danaher Corp, Condalab, Liofilchem, HiMedia Laboratories, Bio-Rad Laboratories Inc, Neogen Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary antimicrobial susceptibility testing market will help companies and investors design strategic landscapes.
Production was the largest segment with a revenue share of 70.14% in 2023. Horizon Databook has segmented the Asia Pacific veterinary antimicrobial susceptibility testing market based on companion, production covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary antimicrobial susceptibility testing market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary antimicrobial susceptibility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account